Esophageal Cancer Molecular Diagnostics Market Outlook:
Esophageal Cancer Molecular Diagnostics Market size was valued at USD 1.5 billion in 2025 and is expected to reach USD 3.39 billion by 2035, registering around 8.5% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of esophageal cancer molecular diagnostics is evaluated at USD 1.61 billion.
The esophageal cancer market is slated to dilate in the upcoming years owing to increased prevalence due to obesity and bad lifestyles, which in turn would snowball into a high dependency on various oesophageal cancer diagnostic equipment.
Additionally, the government and non-government organizations are pushing campaigns in developing countries for people at risk to understand their symptoms, take adequate steps to get diagnosed, and access a tailored treatment plan. With diagnostic tests like bronchoscopy, molecular testing, PET, etc offering a straightforward diagnosis, and predicting the prognosis, the market for esophageal cancer molecular diagnostics is burgeoning even in developing countries now, as the patients are conscious of their options.
